Literature DB >> 21107083

Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors.

Michael W Johnson1, Charles G Eberhart, Arie Perry, Tarik Tihan, Kenneth J Cohen, Marc K Rosenblum, Soroush Rais-Bahrami, Patricia Goldthwaite, Peter C Burger.   

Abstract

To define the spectrum of pilomyxoid morphology and to characterize the association between pilomyxoid astrocytoma (PMA) and pilocytic astrocytoma (PA), 84 cases of pediatric astrocytomas with pilomyxoid features were reviewed. Forty-two of these tumors had coexistent features of PMA and PA ("intermediate"). With the accumulation of more cytoplasm, fibrillar background, microcysts, and thickened blood vessels, these intermediate tumors were more PA-like and less like classic PMA. In the recurrent specimens, PMAs and intermediate tumors sometimes showed more prominent PA features. Both PMA and intermediate tumors involved sites outside the hypothalamus, optic chiasm, and the third ventricle. Both the existence of intermediate tumors and the finding that some PMAs and intermediate tumors mature into PA-like neoplasms over time, provided strong support for a biological relationship between PMA and PA. Additional evidence for a "maturational effect" was the finding that intermediate tumors occurred in patients with a median age of 36 months compared with the median age of 21 months for those with PMAs (P=0.017). Features that were often assumed to be poor prognostic indicators in gliomas, that is, necrosis, mitotic figures, and vascular proliferation, were not uncommon in typical PMAs and intermediate lesions. Further follow-up is needed to more accurately determine the prognosis of intermediate tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107083     DOI: 10.1097/PAS.0b013e3181fd66c3

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  26 in total

Review 1.  The new World Health Organization Classification of Central Nervous System Tumors: what can the neuroradiologist really say?

Authors:  A G Osborn; K L Salzman; M M Thurnher; J H Rees; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-11       Impact factor: 3.825

2.  High accuracy of arterial spin labeling perfusion imaging in differentiation of pilomyxoid from pilocytic astrocytoma.

Authors:  S A Nabavizadeh; R Assadsangabi; M Hajmomenian; M Santi; A Vossough
Journal:  Neuroradiology       Date:  2015-02-10       Impact factor: 2.804

3.  Differential imaging characteristics and dissemination potential of pilomyxoid astrocytomas versus pilocytic astrocytomas.

Authors:  Bálint Alkonyi; Johannes Nowak; Astrid K Gnekow; Torsten Pietsch; Monika Warmuth-Metz
Journal:  Neuroradiology       Date:  2015-02-10       Impact factor: 2.804

4.  Pediatric cerebellar pilomyxoid-spectrum astrocytomas.

Authors:  Jonathan A Forbes; Bret C Mobley; Thomas M O'Lynnger; Calvin M Cooper; Mahan Ghiassi; Rimal Hanif; Matthew M Pearson
Journal:  J Neurosurg Pediatr       Date:  2011-07       Impact factor: 2.375

Review 5.  To BRAF or not to BRAF: is that even a question anymore?

Authors:  Craig Horbinski
Journal:  J Neuropathol Exp Neurol       Date:  2013-01       Impact factor: 3.685

6.  Pilomyxoid Astrocytoma (PMA) Shows Significant Differences in Gene Expression vs. Pilocytic Astrocytoma (PA) and Variable Tendency Toward Maturation to PA.

Authors:  Bette K Kleinschmidt-DeMasters; Andrew M Donson; Hannes Vogel; Nicholas K Foreman
Journal:  Brain Pathol       Date:  2015-01-27       Impact factor: 6.508

7.  Something old and something new about molecular diagnostics in gliomas.

Authors:  Craig Horbinski
Journal:  Surg Pathol Clin       Date:  2012-12-01

8.  Central nervous system tumors in the first year of life: a clinical and pathologic experience from a single cancer center.

Authors:  Maysa Al-Hussaini; Maisa Swaidan; Usama Al-Jumaily; Awni Musharbash
Journal:  Childs Nerv Syst       Date:  2013-03-24       Impact factor: 1.475

9.  Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.

Authors:  Jacquelyn J Roth; Tamara M Fierst; Angela J Waanders; Li Yimei; Jaclyn A Biegel; Mariarita Santi
Journal:  J Neuropathol Exp Neurol       Date:  2016-03-04       Impact factor: 3.685

Review 10.  Pathological and molecular advances in pediatric low-grade astrocytoma.

Authors:  Fausto J Rodriguez; Kah Suan Lim; Daniel Bowers; Charles G Eberhart
Journal:  Annu Rev Pathol       Date:  2012-10-29       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.